Synapse

← Antônio Waldo Zuardi

Papers by Antônio Waldo Zuardi

Page 1 · newest first

  1. Differential Effects of Cannabidiol and Cannabigerol on Cognition, Neuroinflammation, and Blood–Brain Barrier Integrity in a Rat Model of Iron OverloadNeurotoxicity Research · 2026
  2. Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in ratsJournal of Neuroendocrinology · 2026
  3. Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial—DREAMLAND StudyCannabis and Cannabinoid Research · 2026
  4. Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: A randomized, double-blind, placebo-controlled clinical trialJournal of Psychopharmacology · 2025
  5. Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine-model of schizophrenia: sex-dependent effects on positive-like and cognitive impairmentsBrazilian Journal of Psychiatry · 2025
  6. Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonismFrontiers in Pharmacology · 2025
  7. Cannabidiol-Induced Autophagy Ameliorates Tau Protein ClearanceNeurotoxicity Research · 2025
  8. Lack of Acute Agomelatine Effect in a Model of Social Anxiety in Healthy VolunteersJournal of Clinical Psychopharmacology · 2024
  9. Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modificationsActa Neuropsychiatrica · 2024
  10. Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude piloteThe Canadian Journal of Psychiatry · 2023
  11. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal studyFrontiers in Psychiatry · 2023
  12. Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping ReviewCannabis and Cannabinoid Research · 2023
  13. Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain SensitivityPharmaceuticals · 2023
  14. Cannabidiol administration reduces the expression of genes involved in mitochondrial electron transport chain and ribosome biogenesis in mice CA1 neurons2023
  15. Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic AnalysisCannabis and Cannabinoid Research · 2023
  16. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021)Frontiers in Psychiatry · 2023
  17. Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)Pharmaceutics · 2022
  18. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-mazeJournal of Psychopharmacology · 2022
  19. Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysisNeuroscience & Biobehavioral Reviews · 2022
  20. The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical TrialCannabis and Cannabinoid Research · 2022
  21. Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key RecommendationsFrontiers in Pharmacology · 2022
  22. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilliScientific Reports · 2022
  23. Monitoring the Mental Health and Professional Overload of Health Workers in Brazil: A Longitudinal Study Considering the First Wave of the COVID-19 PandemicFrontiers in Psychiatry · 2022
  24. The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger eventBrazilian Journal of Psychiatry · 2022
  25. Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 PandemicJAMA Network Open · 2021
  26. Risk and Protective Factors for the Mental Health of Brazilian Healthcare Workers in the Frontline of COVID-19 PandemicFrontiers in Psychiatry · 2021
  27. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptorsNeuropharmacology · 2021
  28. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle mattersBrazilian Journal of Psychiatry · 2021
  29. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13Frontiers in Molecular Neuroscience · 2021
  30. Cannabidiol (CBD) repurposing as antibacterial: promising therapy of CBD plus polymyxin B against superbugs2021
  31. Cannabidiol for Rapid Eye Movement Sleep Behavior DisorderMovement Disorders · 2021
  32. Cannabidiol induces autophagy via ERK1/2 activation in neural cellsScientific Reports · 2021
  33. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?Frontiers in Pharmacology · 2021
  34. Increased body sway in phobic patients exposed to images of spidersBrazilian Journal of Psychiatry · 2020
  35. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind studyBrazilian Journal of Psychiatry · 2020
  36. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trialsExpert Opinion on Drug Metabolism & Toxicology · 2020
  37. Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal grayJournal of Psychopharmacology · 2020
  38. Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s diseaseJournal of Psychopharmacology · 2020
  39. Oral Cannabidiol Does Not Convert to Δ 8 -THC or Δ 9 -THC in Humans: A Pharmacokinetic Study in Healthy SubjectsCannabis and Cannabinoid Research · 2019
  40. Changes in Cortisol Awakening Response Before and After Development of Posttraumatic Stress Disorder, Which Cannot be Avoided with Use of Cannabidiol: A Case ReportThe Permanente Journal · 2019
  41. Pharmacological interventions during the process of reconsolidation of aversive memories: A systematic reviewNeurobiology of Stress · 2019
  42. Biological bases for a possible effect of cannabidiol in Parkinson’s diseaseBrazilian Journal of Psychiatry · 2019
  43. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking testBrazilian Journal of Psychiatry · 2018
  44. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New AgeFrontiers in Immunology · 2018
  45. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overloadTranslational Psychiatry · 2018
  46. Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of SchizophreniaFrontiers in Pharmacology · 2018
  47. No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover StudyFrontiers in Pharmacology · 2018
  48. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat modelBrazilian Journal of Medical and Biological Research · 2018
  49. Impact of different approaches of primary care mental health on the prevalence of mental disordersPrimary Health Care Research & Development · 2017
  50. Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind studyArchives of Clinical Psychiatry (São Paulo) · 2017